Study Assessing Efficacy and Safety of AKST4290 in Subjects With Parkinson's Disease on Stable Dopaminergic Treatment
Clinical trial NCT04369430 · COMPLETED
Trial details
- NCT number
- NCT04369430
- Sponsor
- Alkahest, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-16
- Primary completion
- 2021-02-11
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.